ACTR-62. A PHASE II STUDY OF TUMOR TREATING FIELDS (TTFIELDS) WITH TEMOZOLOMIDE IN PATIENTS WITH LOW-GRADE GLIOMAS

Approximately 2,000 to 3,000 adults are diagnosed with low-grade gliomas (LGGs) annually in the United States, with a median overall survival ranging from 3–9 years. Radiation and chemotherapy are used to treat LGGs but can increase the risk of transformation to high-grade tumors (HGG) and cause cog...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Juarez, Tiffany, Boucher, Najee, Heng, Annie, Gill, Jaya, Nguyen, Minhdan, Truong, Judy, Saria, Marlon, Achrol, Achal, Barkhoudarian, Garni, Kelly, Daniel, Kesari, Santosh
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.051
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы